Enju Liu1, Abel Makubi, Paul Drain, Donna Spiegelman, David Sando, Nan Li, Guerino Chalamilla, Christopher R Sudfeld, Ellen Hertzmark, Wafaie W Fawzi. 1. aDepartment of Global Health and Population bDepartment of Epidemiology cDepartment of Biostatistics dDepartment of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA eSchool of Medicine, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania fDivision of Infectious Diseases and Medical Practice Evaluation Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA gManagement and Development for Health, Dar es Salaam, Tanzania.
Abstract
OBJECTIVE: The objective of this study is to determine the incidence rate and risk factors of tuberculosis (TB) among HIV-infected adults accessing antiretroviral therapy (ART) in Tanzania. DESIGN: A prospective observational study among HIV-infected adults attending HIV clinics in Dar es Salaam. METHODS: We estimated TB incidence rates among HIV-infected patients prior to and after ART initiation. We used Cox proportional hazard regressions to determine the predictors of incident TB among HIV-infected adults enrolled in the HIV care and treatment programme. RESULTS: We assessed 67 686 patients for a median follow-up period of 24 (interquartile range: 8-49) months; 7602 patients were diagnosed with active TB. The TB incidence rate was 7.9 [95% confidence interval (95% CI), 7.6-8.2] per 100 person-years prior to ART initiation, and 4.4 (95% CI, 4.2-4.4) per 100 person-years for patients receiving ART. In multivariate analyses, patients on ART in the first 3 months had a 57% higher risk of TB (hazard ratio: 1.57, 95% CI, 1.47-1.68) than those not on ART, but the risk significantly decreased with increasing duration of ART. Risk factors for incident TB included being male, having low BMI or middle upper arm circumference, lower CD4 cell count and advanced WHO disease stage. There was seasonal variation for incident TB, with higher risk observed following the rainy seasons (May, June and November). CONCLUSION: In TB endemic regions, HIV-infected patients initiating ART, particularly men and those with poor nutritional status, should be closely monitored for active TB at ART initiation. In addition to increasing the access to ART, interventions should be considered to improve nutritional status among HIV-infected patients.
OBJECTIVE: The objective of this study is to determine the incidence rate and risk factors of tuberculosis (TB) among HIV-infected adults accessing antiretroviral therapy (ART) in Tanzania. DESIGN: A prospective observational study among HIV-infected adults attending HIV clinics in Dar es Salaam. METHODS: We estimated TB incidence rates among HIV-infectedpatients prior to and after ART initiation. We used Cox proportional hazard regressions to determine the predictors of incident TB among HIV-infected adults enrolled in the HIV care and treatment programme. RESULTS: We assessed 67 686 patients for a median follow-up period of 24 (interquartile range: 8-49) months; 7602 patients were diagnosed with active TB. The TB incidence rate was 7.9 [95% confidence interval (95% CI), 7.6-8.2] per 100 person-years prior to ART initiation, and 4.4 (95% CI, 4.2-4.4) per 100 person-years for patients receiving ART. In multivariate analyses, patients on ART in the first 3 months had a 57% higher risk of TB (hazard ratio: 1.57, 95% CI, 1.47-1.68) than those not on ART, but the risk significantly decreased with increasing duration of ART. Risk factors for incident TB included being male, having low BMI or middle upper arm circumference, lower CD4 cell count and advanced WHO disease stage. There was seasonal variation for incident TB, with higher risk observed following the rainy seasons (May, June and November). CONCLUSION: In TB endemic regions, HIV-infectedpatients initiating ART, particularly men and those with poor nutritional status, should be closely monitored for active TB at ART initiation. In addition to increasing the access to ART, interventions should be considered to improve nutritional status among HIV-infectedpatients.
Authors: Stephen D Lawn; Katharina Kranzer; David J Edwards; Matthew McNally; Linda-Gail Bekker; Robin Wood Journal: AIDS Date: 2010-06-01 Impact factor: 4.177
Authors: E Martín-Echevarria; S Serrano-Villar; T Sainz; A Moreno; J L Casado; F Dronda; M J Pérez Elías; E Navas; M Rodríguez Zapata; S Moreno Journal: Int J Tuberc Lung Dis Date: 2014-09 Impact factor: 2.373
Authors: R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson Journal: Lancet Date: 2000-02-19 Impact factor: 79.321
Authors: Maxwell O Akanbi; Chad J Achenbach; Joe Feinglass; Babafemi Taiwo; Adamu Onu; Mai T Pho; Oche Agbaji; Phyllis Kanki; Robert L Murphy Journal: AIDS Res Hum Retroviruses Date: 2013-02-25 Impact factor: 2.205
Authors: William Worodria; Marguerite Massinga-Loembe; Harriet Mayanja-Kizza; Jane Namaganda; Andrew Kambugu; Yukari C Manabe; Luc Kestens; Robert Colebunders Journal: Clin Dev Immunol Date: 2010-12-08
Authors: A R Martineau; A C C S Leandro; S T Anderson; S M Newton; K A Wilkinson; M P Nicol; S M Pienaar; K H Skolimowska; M A Rocha; V C Rolla; M Levin; R N Davidson; S A Bremner; C J Griffiths; B S Eley; M G Bonecini-Almeida; R J Wilkinson Journal: Eur Respir J Date: 2009-09-24 Impact factor: 16.671
Authors: Amitabh B Suthar; Stephen D Lawn; Julia del Amo; Haileyesus Getahun; Christopher Dye; Delphine Sculier; Timothy R Sterling; Richard E Chaisson; Brian G Williams; Anthony D Harries; Reuben M Granich Journal: PLoS Med Date: 2012-07-24 Impact factor: 11.069
Authors: Kosuke Kawai; Claudia A Hawkins; Ellen Hertzmark; Joel M Francis; David Sando; Aisa N Muya; Nzovu Ulenga; Wafaie W Fawzi Journal: Am J Trop Med Hyg Date: 2018-01-04 Impact factor: 2.345
Authors: J Morgan Freiman; Karen R Jacobson; Winnie R Muyindike; C Robert Horsburgh; Jerrold J Ellner; Judith A Hahn; Benjamin P Linas Journal: J Acquir Immune Defic Syndr Date: 2018-04-01 Impact factor: 3.731
Authors: Ka Lai Yee; Sauzanne G Khalilieh; Rosa I Sanchez; Rachael Liu; Matt S Anderson; Helen Manthos; Timothy Judge; John Brejda; Joan R Butterton Journal: Clin Drug Investig Date: 2017-07 Impact factor: 2.859
Authors: Sauzanne G Khalilieh; Ka Lai Yee; Rosa I Sanchez; Li Fan; Matt S Anderson; Monali Sura; Tine Laethem; Scott Rasmussen; Luc van Bortel; Griet van Lancker; Marian Iwamoto Journal: Antimicrob Agents Chemother Date: 2019-04-25 Impact factor: 5.191
Authors: Nang T T Kyaw; Ajay M V Kumar; Anthony D Harries; Srinath Satyanarayana; Nay L Oo; Matthew J Hayat; Kenneth G Castro; Matthew J Magee Journal: AIDS Date: 2022-01-01 Impact factor: 4.177
Authors: Charlotte A Chang; Seema Thakore Meloni; Geoffrey Eisen; Beth Chaplin; Patrick Akande; Prosper Okonkwo; Holly E Rawizza; Eric Tchetgen Tchetgen; Phyllis J Kanki Journal: Open Forum Infect Dis Date: 2015-10-17 Impact factor: 3.835